Open Accessoverview of the appropriability mechanisms used in plant biotechnology industry
Author(s) -
Vinícius Eduardo Ferrari,
José Maria Jardim Ferreira da Silveira,
Maria Ester Dal-Poz
Publication year - 2019
Language(s) - English
Resource type - Journals
ISSN - 2411-2933
DOI - 10.31686/ijier.vol7.iss8.1687
Subject(s) - intellectual property , competitor analysis , microbiology and biotechnology , imitation , agricultural biotechnology , business , battle , industrial organization , agriculture , biology , marketing , law , political science , history , ecology , archaeology , neuroscience
This paper aims to discuss the main appropriability mechanisms used by biotech firms to avoid imitation and appropriate the economic benefits from crop innovations. To this end, we analyze the strategic links between the technological development of genetically modified organisms (GMO) and the ownership rights over plant transformation technologies. We also discuss a key case study - the legal battle between Monsanto and Syngenta by the control of the GMO crops derived from the GA21 gene. Our findings show that a system of blocking patents has been built basically through strategies relating to intellectual property mechanisms. As result, Monsanto's efforts to sue competitors for patent infringement have proved to be a successful barrier to entry in plant biotechnology industry.